From drug response profiling to target addiction scoring in cancer cell models

Por Yadav, Bhagwan, Gopalacharyulu, Peddinti, Pemovska, Tea, Khan, Suleiman A., Szwajda, Agnieszka, Tang, Jing, Wennerberg, Krister, Aittokallio, Tero
Publicado no Dis Model Mech (2015)

Indexes of Insulin Resistance in Hyperinsulinemic Polycystic Ovary Syndrome in a Macedonian Cohort of Women of Reproductive Age: A Cross-Sectional Study

Por Jovanovska-Mishevska, Sasha, Atanasova-Boshku, Aleksandra, Bitoska, Iskra, Ahmeti, Irfan, Todorova, Biljana, Pemovska, Gordana, Milenkovic, Tatjana, Krstevska, Brankica
Publicado no Open Access Maced J Med Sci (2016)

Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia

Por Eldfors, S, Kuusanmäki, H, Kontro, M, Majumder, M M, Parsons, A, Edgren, H, Pemovska, T, Kallioniemi, O, Wennerberg, K, Gökbuget, N, Burmeister, T, Porkka, K, Heckman, C A
Publicado no Leukemia (2017)

Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML

Por Malani, D, Murumägi, A, Yadav, B, Kontro, M, Eldfors, S, Kumar, A, Karjalainen, R, Majumder, M M, Ojamies, P, Pemovska, T, Wennerberg, K, Heckman, C, Porkka, K, Wolf, M, Aittokallio, T, Kallioniemi, O
Publicado no Leukemia (2017)

Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies

Por Yadav, Bhagwan, Pemovska, Tea, Szwajda, Agnieszka, Kulesskiy, Evgeny, Kontro, Mika, Karjalainen, Riikka, Majumder, Muntasir Mamun, Malani, Disha, Murumägi, Astrid, Knowles, Jonathan, Porkka, Kimmo, Heckman, Caroline, Kallioniemi, Olli, Wennerberg, Krister, Aittokallio, Tero
Publicado em 2014

Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing

Por Pietarinen, P O, Pemovska, T, Kontro, M, Yadav, B, Mpindi, J P, Andersson, E I, Majumder, M M, Kuusanmäki, H, Koskenvesa, P, Kallioniemi, O, Wennerberg, K, Heckman, C A, Mustjoki, S, Porkka, K
Publicado no Blood Cancer J (2015)

Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors

Por Pietarinen, Paavo O., Eide, Christopher A., Ayuda-Durán, Pilar, Potdar, Swapnil, Kuusanmäki, Heikki, Andersson, Emma I., Mpindi, John P., Pemovska, Tea, Kontro, Mika, Heckman, Caroline A., Kallioniemi, Olli, Wennerberg, Krister, Hjorth-Hansen, Henrik, Druker, Brian J., Enserink, Jorrit M., Tyner, Jeffrey W., Mustjoki, Satu, Porkka, Kimmo
Publicado no Oncotarget (2017)